Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Gray platelet syndrome: proinflammatory megakaryocytes and α-granule loss cause myelofibrosis and confer metastasis resistance in mice.

Jose A Guerrero | Cavan Bennett | Louise van der Weyden | Harriet McKinney | Melody Chin | Paquita Nurden | Zoe McIntyre | Emma L Cambridge | Jeanne Estabel | Hannah Wardle-Jones | Anneliese O Speak | Wendy N Erber | Augusto Rendon | Willem H Ouwehand | Cedric Ghevaert
Blood | 2014

NBEAL2 encodes a multidomain scaffolding protein with a putative role in granule ontogeny in human platelets. Mutations in NBEAL2 underlie gray platelet syndrome (GPS), a rare inherited bleeding disorder characterized by a lack of α-granules within blood platelets and progressive bone marrow fibrosis. We present here a novel Nbeal2(-/-) murine model of GPS and demonstrate that the lack of α-granules is due to their loss from platelets/mature megakaryocytes (MKs), and not by initial impaired formation. We show that the lack of Nbeal2 confers a proinflammatory phenotype to the bone marrow MKs, which in combination with the loss of proteins from α-granules drives the development of bone marrow fibrosis. In addition, we demonstrate that α-granule deficiency impairs platelet function beyond their purely hemostatic role and that Nbeal2 deficiency has a protective effect against cancer metastasis.

Pubmed ID: 25258341

Research resources used in this publication

None found

Additional research tools detected in this publication

Antibodies used in this publication

None found

Associated grants

  • Agency: British Heart Foundation, United Kingdom
    Id: RG/09/012/28096
  • Agency: British Heart Foundation, United Kingdom
    Id: FS/14/40/30921
  • Agency: British Heart Foundation, United Kingdom
    Id: FS/09/039/27788
  • Agency: Cancer Research UK, United Kingdom
    Id: 13031
  • Agency: Department of Health, United Kingdom
    Id: RP-PG-0310-1002
  • Agency: Wellcome Trust, United Kingdom
    Id: WT098051
  • Agency: British Heart Foundation, United Kingdom
    Id: FS09/039
  • Agency: British Heart Foundation, United Kingdom
    Id: RG/09/12/28096

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


International Mouse Phenotyping Consortium (IMPC) (tool)

RRID:SCR_006158

Center that produces knockout mice and carries out high-throughput phenotyping of each line in order to determine function of every gene in mouse genome. These mice will be preserved in repositories and made available to scientific community representing valuable resource for basic scientific research as well as generating new models for human diseases.

View all literature mentions